Hit compounds were confirmed in dose response experiments and further analyzed for their ability to inhibit STAT3 phosphorylation, downregulate STAT3- and STAT1-driven gene expression, and for their potential to impair the viability in STAT3-dependent and -independent cancer cell lines. Here, STAT3 is linked to cancer.